Combo anesthesia effective, well tolerated in phaco patients

Article

Combined topical and intracameral anesthesia without sedatives is well tolerated by most phacoemulsification patients, according to results of a large, population-based series of small-incision phacoemulsification surgery. In addition, this anesthetic regimen was also effective in cases where complications or adverse events occurred.

Luleå, Sweden-Combined topical and intracameral anesthesia without sedatives is well tolerated by most phacoemulsification patients, according to results of a large, population-based series of small-incision phacoemulsification surgery. In addition, this anesthetic regimen was also effective in cases where complications or adverse events occurred.

Swedish researchers conducted a prospective observational study on all cases (N = 1,249) of cataract surgery during a 1-year period at Sunderby Hospital, Luleå, Sweden. Most patients administered dilating drops at home consisting of phenylephrine (2.5%) and cyclopentolate (1%) one drop, three times each, 15 minutes apart, starting 1 hour before leaving home. Upon arriving at the clinic, nurses administered additional mydriatic drops if necessary. Any patients who felt any anxiety were asked if they would prefer preoperative sedation, consisting of sublingual midazolam hydrochloride. Doses were determined by patient age and body weight; most patients received 2 mg to 3 mg.

Before eyes were rinsed with chlorhexidine solution (0.5 mg/mL), one drop of preservation-free amethocaine hydrochloride (1%) was given, followed a few minutes later by another drop. At the beginning of the procedure, a small dose (0.2 mL) of preservative-free lidocaine hydrochloride (1%; 10 mg/mL) is given intracamerally by the surgery. Patients who experienced pain during the procedure were given additional anesthesia: either topical amethocaine hydrochloride (1%) and/or additional intracameral lidocaine hydrochloride (1%).

A full 90% of patients had combined topical and intracameral anesthesia without sedation. Those who chose preoperative sedation were significantly younger (P = 0.0001) and more often female (P = 0.011).

A subgroup of patients (n = 12) was asked to complete short questionnaires to assess their satisfaction with the anesthetic regimen. In these patients, the median pain score after surgery was 0.7 (visual analog scale, 0-10). Pain scores of 1.9 or less were reported by 76% of patients. Those reporting a pain score of ≥ 2 received sedation and additional anesthetics more often.

No significant differences were seen in regards to age, sex, pulse rate, oxygen saturation, first or second eye surgery, or adverse intraoperative events in patients with pain scores of ≤ 1.9 and ≥ 2. In addition, no significant differences were seen in the percentage of complications or adverse events between patients who had sedation and those without sedation (6.4% vs. 7.2%, respectively; P = 0.94).

The abstract can be accessed: here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.